TPST Company Profile and Key Details

Q: Who are the executives of TPST?

Dr. Sharon Sakai Ph.D., RACHead of Regulatory & QualityMr. Stephen R. Brady J.D., LLMChief Executive Officer & DirectorDr. Thomas W. Dubensky Jr., Ph.D.Pres & DirectorDr. Samuel Whiting M.D., Ph.D.Executive Vice President & Chief Medical OfficerMr. Petpiboon PrasitActing Chief Scientific Officer & Executive DirectorMr. Justin TrojanowskiCorporation Controller, Treasurer & Principal Accounting OfficerDr. Anne MoonSenior Vice President and Head of Project Team Leadership, Project Management & Portfolio ManagementMr. Nicholas MaestasVice President of Strategy & Fin. and Sec.

NASDAQ : TPST

Tempest Therapeutics

$0.75

-0.0301-3.84%

Open: 10:49 AM

56.08

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Tempest Therapeutics, Inc. (TPST) stock declined over -3.84%, trading at $0.75 on NASDAQ, down from the previous close of $0.78. The stock opened at $0.80, fluctuating between $0.74 and $0.80 in the recent session.

Stock Snapshot

0.7843

Prev. Close

12.05M

Market Cap

0.74

Day Low

-0.18

P/E Ratio

-4.28

EPS (TTM)

-1.28

Cash Flow per Share

0.8

Open

15.98M

Number of Shares

0.799

Day High

87.55%

Free Float in %

1.24

Book Value

48.21K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 14, 2026	0.80	0.82	0.75	0.78	138.57K
Sep 11, 2026	0.79	0.89	0.76	0.81	772.66K
Sep 10, 2026	0.95	0.95	0.80	0.80	378.8K
Sep 09, 2026	0.99	0.99	0.91	0.91	185.35K
Sep 08, 2026	1.02	1.03	0.98	0.99	198.66K
Sep 04, 2026	1.04	1.05	1.01	1.03	206.59K
Sep 03, 2026	1.10	1.10	1.04	1.05	181.95K
Sep 02, 2026	1.05	1.12	1.05	1.10	126.51K
Sep 01, 2026	1.07	1.08	1.03	1.05	158.93K
Aug 31, 2026	1.06	1.13	1.06	1.09	58.91K
Aug 28, 2026	1.09	1.10	1.04	1.06	62.11K
Aug 27, 2026	1.10	1.11	1.07	1.08	69.44K
Aug 26, 2026	1.11	1.11	1.07	1.08	51.73K
Aug 25, 2026	1.11	1.13	1.08	1.11	75.24K
Aug 24, 2026	1.05	1.14	1.01	1.10	198.83K
Aug 21, 2026	1.02	1.08	1.00	1.04	130.34K
Aug 20, 2026	1.05	1.07	1.00	1.02	89.52K
Aug 19, 2026	1.02	1.08	1.02	1.07	151.62K
Aug 18, 2026	1.11	1.11	1.01	1.07	0
Aug 17, 2026	1.09	1.17	1.05	1.13	816.06K

Contact Details

Brisbane, CA 94005

United States

https://www.tempesttx.com 415 798 8589

About Company

Tempest Therapeutics Inc. is an oncology company, currently in the clinical development phase, dedicated to advancing novel small molecule drugs designed to combat cancer. The firm's pipeline highlights two key therapeutic candidates: TPST-1495, a compound functioning as a dual inhibitor of EP2 and EP4 receptors (which are implicated in prostaglandin E2 signaling), currently undergoing initial human trials for solid tumor indications. The second candidate, TPST-1120, is a targeted blocker of peroxisome proliferator-activated receptor alpha, also progressing through Phase 1 studies for solid tumors. Beyond these clinical assets, Tempest is exploring TREX-1, a pivotal cellular enzyme known for its role in regulating the innate immune response within cancerous growths. Established in 2011, Tempest Therapeutics Inc. is headquartered in South San Francisco, California, having previously operated as a subsidiary of Inception Sciences, Inc.

Stock Peers

ARGX

6.15+0.62%

argenx SE$990.54 REGN

12.25+1.57%

Regeneron Pharmaceuticals, Inc.$793.74 MDGL

5.57+1.04%

Madrigal Pharmaceuticals, Inc.$540.06 VRTX

4.07+0.79%

Vertex Pharmaceuticals Incorporated$519.51 UTHR

5.59+1.12%

United Therapeutics Corporation$502.70 ONC

7.32+2.11%

BeOne Medicines AG$353.83 KRYS

-6.97-2.01%

Krystal Biotech, Inc.$340.03 PRAX

-4.03-1.20%

Praxis Precision Medicines, Inc.$330.55 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

-3.82-1.34%

Ligand Pharmaceuticals Incorporated$280.65

Frequently Asked Questions

What is the current Tempest Therapeutics, Inc. (TPST) stock price?

Tempest Therapeutics, Inc. (NASDAQ: TPST) stock price is $0.75 in the last trading session. During the trading session, TPST stock reached the peak price of $0.80 while $0.74 was the lowest point it dropped to. The percentage change in TPST stock occurred in the recent session was -3.84% while the dollar amount for the price change in TPST stock was - $0.03.

TPST's industry and sector of operation?

The NASDAQ listed TPST is part of Biotechnology industry that operates in the broader Healthcare sector. Tempest Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of TPST?

Dr. Sharon Sakai Ph.D., RAC
Head of Regulatory & Quality
Mr. Stephen R. Brady J.D., LLM
Chief Executive Officer & Director
Dr. Thomas W. Dubensky Jr., Ph.D.
Pres & Director
Dr. Samuel Whiting M.D., Ph.D.
Executive Vice President & Chief Medical Officer
Mr. Petpiboon Prasit
Acting Chief Scientific Officer & Executive Director
Mr. Justin Trojanowski
Corporation Controller, Treasurer & Principal Accounting Officer
Dr. Anne Moon
Senior Vice President and Head of Project Team Leadership, Project Management & Portfolio Management
Mr. Nicholas Maestas
Vice President of Strategy & Fin. and Sec.

How TPST did perform over past 52-week?

TPST's closing price is 4.1% higher than its 52-week low of $0.74 where as its distance from 52-week high of $12.23 is -93.59%.

How many employees does TPST have?

Number of TPST employees currently stands at 4.

Link for TPST official website?

Official Website of TPST is: https://www.tempesttx.com

How do I contact TPST?

TPST could be contacted at phone 415 798 8589 and can also be accessed through its website. TPST operates from 2000 Sierra Point Parkway, Brisbane, CA 94005, United States.

How many shares of TPST are traded daily?

TPST stock volume for the day was 48.21K shares. The average number of TPST shares traded daily for last 3 months was 233.72K.

What is the market cap of TPST currently?

The market value of TPST currently stands at $12.05M with its latest stock price at $0.75 and 15.98M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	4
Beta	-1.66
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	4
Beta	-1.66
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

TPST Company Profile and Key Details

Tempest Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Financial & Profitability Overview

Quarterly Financial Highlights

Technical Performance

Earnings & Analyst Outlook

Shareholding & Insider Activity

Dividend & Fair Value

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways